EXPERT CONSENSUS. ROLE OF COMBINATION LIPID-LOWERING THERAPY (SIMVASTATIN/EZETIMIBE 20/10 MG) IN THE CORRECTION OF LIPID METABOLISM DISTURBANCES IN PATIENTS WITH CHRONIC KIDNEY DISEASE

EXPERT CONSENSUS. ROLE OF COMBINATION LIPID-LOWERING THERAPY (SIMVASTATIN/EZETIMIBE 20/10 MG) IN THE CORRECTION OF LIPID METABOLISM DISTURBANCES IN PATIENTS WITH CHRONIC KIDNEY DISEASE

Expert Consensus. Role of combination lipid-lowering therapy (simvastatin/ezetimibe 20/10 mg) in the correction of lipid metabolism disturbances in patients with chronic kidney disease.

Saved in:

Bibliographic Details
Main Authors:	A. Catapano, E. V. Shlyakhto, A. I. Martynov, R. G. Oganov, V. V. Kukharchuk, M. V. Shestakova, A. S. Ametov, S. A. Boicov, M. G. Bubnova, S. V. Villevalde, A. S. Galyavich, Yu. A. Karpov, J. D. Kobalava, O. N. Koziolova
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2013-08-01
Series:	Кардиоваскулярная терапия и профилактика
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/217
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Simultaneous Determination of Simvastatin and Ezetimibe in Tablets by HPLC
by: D. Anantha Kumar, et al.
Published: (2009-01-01)

Ezetimibe potential in cardiology practice
by: A. A. Lyakishev, et al.
Published: (1970-01-01)

Combined lipid lowering therapy, including ezetimibe, in the post-infarction period
by: V. E. Oleynikov, et al.
Published: (2024-05-01)

Simultaneous HPTLC Estimation of Simvastatin and Ezetimibe in Tablet Dosage Form
by: Bhupendra Shrestha, et al.
Published: (2010-01-01)

Microemulsion Liquid Chromatographic Method for Simultaneous Determination of Simvastatin and Ezetimibe in Their Combined Dosage Forms
by: Mohammed E. A. Hammouda, et al.
Published: (2013-01-01)

Simultaneous inhibition of cholesterol absorption and synthesis in combined therapy with ezetimibe and simvastatin
by: D. M. Aronov
Published: (2005-08-01)

Disorders of lipid metabolism. Clinical Guidelines 2023
by: M. V. Ezhov, et al.
Published: (2023-06-01)

Serum lipids and smoking status in coronary heart disease patients treated with simvastatin
by: L. R. Gazdanova, et al.
Published: (2010-04-01)

ESCADRA: a randomised study. Part I: lipid-lowering effectiveness, safety and tolerability of ezetimibe, initial doses of original statins, and the combination of ezetimibe with initial doses of statins in patients with coronary heart disease and hyperlipidemia
by: M. Yu. Zubareva, et al.
Published: (2010-12-01)

Effect of different statins and EZETIMIBE/SIMVASTATIN on cardiovascular disease in patients with chronic kidney disease
by: ZHANG Xue-qing, et al.
Published: (2018-01-01)

Lipid-lowering treatment in the improvement of outcomes in patients with atherosclerotic cardiovascular disease and diabetes mellitus: the role of PCSK9 inhibitors
by: G. R. Galstyan, et al.
Published: (2018-12-01)

Rationale for dapagliflozin administration for the prevention of adverse outcomes in patients with heart failure with reduced ejection fraction. Expert consensus statement
by: S. N. Tereshchenko, et al.
Published: (2020-06-01)

Interdisciplinary Expert Consensus: the place of original pitavastatin in primary and secondary prevention of cardiovascular diseases
by: M. G. Bubnova, et al.
Published: (2024-12-01)

Clinical effects of statins: focusing on simvastatin
by: D. M. Aronov, et al.
Published: (2009-04-01)

Combined lipid-lowering therapy: choosing strategy and tactics
by: N. A. Koziolova
Published: (2010-08-01)

Cost-effectiveness analysis of using atorvastatin, simvastatin, ezetimibe, alirocumab, evolocumab, inclisiran in adults with very high cardiovascular risk under the preferential drug provision program
by: T. O. Bessonova, et al.
Published: (2023-04-01)

Phytoactive-Loaded Lipid Nanocarriers for Simvastatin Delivery: A Drug Repositioning Strategy Against Lung Cancer
by: Rocío Gambaro, et al.
Published: (2025-02-01)

Simvastatin-Induced Insulin Resistance May Be Linked to Decreased Lipid Uptake and Lipid Synthesis in Human Skeletal Muscle: the LIFESTAT Study
by: Steen Larsen, et al.
Published: (2018-01-01)

EFFECT OF SIMVASTATIN ON MARKERS OF CARDIOVASCULAR RISK
by: N. V. Perova, et al.
Published: (2016-01-01)

Dexamethasone, celecoxib, and simvastatin-induced 5-fluorouracil resistance in cancer cells: a possible role of lipid droplet accumulation
by: Duaa S. Sabbah, et al.
Published: (2025-07-01)

GENETIC PREDICTORS OF INTENSIVE LIPID-LOWERING THERAPY EFFICACY AND ITS ANTI-INFLAMMATORY EFFECTS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS
by: M. A. Vorobyeva, et al.
Published: (2017-09-01)

Implemented models and perspectives of managing lipid metabolism disorders. Concept of rare lipid disease centers
by: A. S. Alieva, et al.
Published: (2021-07-01)

Safety of ezetimibe in lipid-lowering treatment: systematic review and meta-analysis of randomised controlled trials and cohort studies
by: Ling Li, et al.
Published: (2022-12-01)

Lipid-lowering effectiveness of a Russian generic of atorvastatin in patients with various hyperlipidaemia phenotypes
by: P. P. Malyshev, et al.
Published: (2009-12-01)

Comparison of Simvastatin and Rosuvastatin in Oxidation and Antioxidant Levels in Male Rabbits Infected with Experimental Lipid Disorder
by: Maysam Ibrahim Mahdi Al-Naisani, et al.
Published: (2019-11-01)

Efficacy comparison of rosuvastatin vs simvastatin on blood lipid and microinflammatory state in the maintenance hemodialysis patients
by: XU Fang, et al.
Published: (2017-01-01)

Lipids in parenteral nutrition – expert consensus statements: Translating guidelines into clinical practice
by: Robert G. Martindale, et al.
Published: (2025-04-01)

Simvastatin therapy in climacteric women with atherogenic dyslipoproteinemias
by: N. V. Izmozherova, et al.
Published: (2008-04-01)

From lipid analysis to lipidomics
by: V. A. Akmurzina, et al.
Published: (2012-12-01)

Combination of statin and ezetimibe in the post-infarction period
by: Valentin E. Oleynikov, et al.
Published: (2024-12-01)

Outpatient Practice of Lipid-Lowering Therapy Prescription (According to the ARGO-3 Study)
by: M. V. Ezhov, et al.
Published: (2023-05-01)

Simvastatin therapy in patients with hepatic disease
by: O. M. Drapkina, et al.
Published: (2007-10-01)

THE EFFICACY OF HIGH-DOSE SIMVASTATIN IN ACUTE PERIOD OF ISCHEMIC STROKE
by: V. V. Yakusevich, et al.
Published: (2015-12-01)

BLOOD LIPID AND NON-LIPID BIOMARKERS IN NOVOSIBIRSK MEN WITH CORONARY ATHEROSCLEROSIS
by: Yu. I. Ragino, et al.
Published: (2009-04-01)

Effectiveness of fixed-dose combination of rosuvastatin and ezetimibe in heterozygous familial hypercholesterolemia from the RENAISSANCE registry
by: I. A. Alekseeva, et al.
Published: (2025-08-01)

Species Differences in Ezetimibe Glucuronidation
by: Shalom Emmanuel, et al.
Published: (2024-10-01)

EFFECTIVENESS AND SAFETY OF LISINOPRIL AND SIMVASTATIN COMBINATION – ELASTICA STUDY RESULTS
by: F. T. Ageev, et al.
Published: (2009-02-01)

Evaluation of the effectiveness of lipid-lowering agents
by: V. G. Shevko, et al.
Published: (2020-02-01)

Effect of Simvastatin on the spectrum of blood plasma fat acids change in the patients with ischemia heart disease
by: V. V. Novitsky, et al.
Published: (2008-09-01)

ANTIISCHEMIC AND ANTIARRHYTHMIC EFFECTS OF SIMVASTATIN IN PATIENTS WITH DIASTOLIC HEART FAILURE
by: T. V. Pinchuk, et al.
Published: (2013-12-01)